New research reveals that individuals who stop using new GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who stop conventional lifestyle programs.
Research printed in a prominent health publication demonstrates that while obese individuals frequently drop about a fifth of their body weight while on the medication, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"Users using these medications should be cognizant of the potential of rapid rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb.
Such speed of recovery means a return to original mass in about one and a half years.
Analyzing Therapies
The analysis, which examined 37 of studies involving thousands of patients, contrasted the results of these new drugs with other pills.
Researchers point out that people who shed pounds through diet and exercise generally see a slower creep back—around 0.1 kg a month—once they finish.
Understanding the Quick Regain
Nutrition scientists suggest the way of the drugs accounts for the accelerated regain.
The injections copy a body's own chemical called GLP-1, which moderates appetite.
"Artificially providing the hormone concentrations several times higher than normal might result in the system to produce less of its endogenous hormone, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the jabs for people with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Professionals say that, given the high risk of relapse, the treatment might need to be long-term.
This perspective is echoed by drug manufacturers, who state that the findings "highlight the chronic character of obesity," comparing it to managing diseases like high blood pressure.
User Accounts
People who have come off the jabs report a powerful return of cravings.
"I experienced a switch flipping and you become extremely hungry," said one woman.
This difficulty is exacerbated if patients have not developed sustainable lifestyle or habit changes during treatment.
Widespread Interest
Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among women compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Ultimately, researchers stress that while these medications are effective tools for weight loss, they are not a permanent fix and long-term success hinges on combined behavioural changes.
